Find Sacubitril-Valsartan manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sacubitril valsartan sodium hydrate, Sacubitril mixture with valsartan, Wb8ft61183, Lcz 696, Sacubitril valsartan sodium hydrate (jan), Sacubitril valsartan sodium hydrate [jan]
Molecular Formula
C96H120N12Na6O21
Molecular Weight
1916.0  g/mol
InChI Key
ZASXKEGREHRXDL-CAWNUZPDSA-H
FDA UNII
WB8FT61183

Sacubitril-Valsartan
Sacubitril/Valsartan is a combination of sacubitril and valsartan with natriuretic and anti-hypertensive properties. Upon administration, sacubitril is metabolized by esterases to its active metabolite, LBQ657 (sacubitrilat), which inhibits neprilysin, a neutral endopeptidase that cleaves natriuretic peptides such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and c-type natriuretic peptide (CNP), as well as certain vasoconstricting peptides including as angiotensin I and II, and endothelin-1. Inhibition of neprilysin leads to increased concentrations of endogenous natriuretic peptides, which function to activate downstream receptors that promote vasodilation, natriuresis and diuresis, while simultaneously increasing the concentration of vasoconstricting peptides such as angiotensin II. Co-administration with valsartan, an angiotensin II receptor blocker, prevents the vasoconstrictive effects of neprilysin inhibition and promotes a decrease in vascular resistance and blood pressure.
1 2D Structure

Sacubitril-Valsartan

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
hexasodium;4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate;(2S)-3-methyl-2-[pentanoyl-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]amino]butanoate;pentahydrate
2.1.2 InChI
InChI=1S/2C24H29N5O3.2C24H29NO5.6Na.5H2O/c2*1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23;2*1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19;;;;;;;;;;;/h2*6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H2,25,26,27,28,31,32);2*4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28);;;;;;;5*1H2/q;;;;6*+1;;;;;/p-6/t2*22-;2*17-,21+;;;;;;;;;;;/m0011.........../s1
2.1.3 InChI Key
ZASXKEGREHRXDL-CAWNUZPDSA-H
2.1.4 Canonical SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)C(C(C)C)C(=O)[O-].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)C(C(C)C)C(=O)[O-].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
2.1.5 Isomeric SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
2.2 Other Identifiers
2.2.1 UNII
WB8FT61183
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate

2. Lcz 696

3. Lcz-696

4. Lcz696

5. Sacubitril And Valsartan Drug Combination

6. Sacubitril And Valsartan Sodium Anhydrous Drug Combination

7. Sacubitril And Valsartan Sodium Hydrate Drug Combination

8. Sacubitril Valsartan Drug Combination

9. Sacubitril Valsartan Sodium Anhydrous

10. Sacubitril Valsartan Sodium Hydrate

11. Sacubitril-valsartan

12. Sacubitril-valsartan Sodium Anhydrous Drug Combination

13. Sacubitril-valsartan Sodium Hydrate Drug Combination

14. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate

2.3.2 Depositor-Supplied Synonyms

1. Sacubitril Valsartan Sodium Hydrate

2. Sacubitril Mixture With Valsartan

3. Wb8ft61183

4. Lcz 696

5. Sacubitril Valsartan Sodium Hydrate (jan)

6. Sacubitril Valsartan Sodium Hydrate [jan]

7. Entresto (tn)

8. Unii-wb8ft61183

9. Valsartan Mixture With Ahu-377

10. Ex-a2849

11. Mfcd29477717

12. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate

13. Ac-29037

14. Sucabitril Valsartan Sodium Hydrate

15. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate

16. D10226

17. Valsartan Ahu-377 Sodium Hemipentahydrate

18. Q27292546

19. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With .alpha.-ethyl (.alpha.r,.gamma.s)-.gamma.-((3-carboxy-1-oxopropyl)amino)-.alpha.-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)

20. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With Alpha-ethyl(alphar,gammas)-gamma-((3-carboxy-1-oxopropyl)amino)-alpha-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)

2.4 Create Date
2013-05-27
3 Chemical and Physical Properties
Molecular Weight 1916.0 g/mol
Molecular Formula C96H120N12Na6O21
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count29
Rotatable Bond Count40
Exact Mass1915.8110694 g/mol
Monoisotopic Mass1914.8077146 g/mol
Topological Polar Surface Area396 Ų
Heavy Atom Count135
Formal Charge0
Complexity1140
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count15
4 Drug and Medication Information
4.1 Drug Indication

Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Angiotensin Receptor Antagonists

Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. (See all compounds classified as Angiotensin Receptor Antagonists.)


5.2 ATC Code

C09DX04


API SUPPLIERS

read-more
read-more

01

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WCarrow-down NDC KDMF arrow-down VMF Others AUDIT
Dr Reddy Company Banner

02

Polpharma

Poland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF ASMF arrow-down AUDIT
Polpharma CB

03

Faran Shimi Pharmaceutical

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Flag Iran
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Faran Shimi Pharmaceutical

04

Virupaksha Organics

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Virupaksha

05

Ami Lifesciences Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
AMI Lifesciences

06

Aptra Synthesis

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Aptra Synthesis

07

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
HRV Global Life Sciences

08

Octavius Pharma Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Octavius Pharma

09

Zhuhai Rundu Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Zhuhai Rundu Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

HONOUR LAB LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

HONOUR LAB LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

CPHI Middle east
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2017-12-22

Pay. Date : 2017-11-08

DMF Number : 31574

Submission : 2017-08-29

Status : Active

Type : II

Dr Reddy Company Banner

02

CPHI Middle east
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2018-09-04

Pay. Date : 2017-12-20

DMF Number : 32337

Submission : 2017-12-21

Status : Active

Type : II

Polpharma CB

03

CPHI Middle east
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 37994

Submission : 2023-03-09

Status : Active

Type : II

AMI Lifesciences

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI offers customized CDMO Solutions for API development and manufacturing services.

Flag Israel
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2019-04-12

Pay. Date : 2018-12-20

DMF Number : 33457

Submission : 2019-02-28

Status : Active

Type : II

TAPI Company Banner

05

Harman Finochem Ltd

India

USDMF

arrow
CPHI Middle east
Not Confirmed

05

CPHI Middle east
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-03-27

Pay. Date : 2019-02-05

DMF Number : 33452

Submission : 2019-02-01

Status : Active

Type : II

blank

06

Lupin Ltd

India

USDMF

arrow
CPHI Middle east
Not Confirmed

07

CPHI Middle east
Not Confirmed

07

CPHI Middle east
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-03-08

Pay. Date : 2019-02-01

DMF Number : 33455

Submission : 2019-01-10

Status : Active

Type : II

blank

08

CPHI Middle east
Not Confirmed

09

CPHI Middle east
Not Confirmed

09

10

CPHI Middle east
Not Confirmed
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 59651-335

Start Marketing Date : 2024-01-25

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (43kg/50kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 66064-1026

Start Marketing Date : 2017-01-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

03

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69037-0040

Start Marketing Date : 2015-07-07

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69037-0039

Start Marketing Date : 2015-07-07

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69037-0043

Start Marketing Date : 2015-07-07

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM ANHYDROUS

NDC Package Code : 69766-045

Start Marketing Date : 2017-12-29

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69766-042

Start Marketing Date : 2017-12-15

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69766-062

Start Marketing Date : 2018-12-31

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 64220-222

Start Marketing Date : 2024-07-23

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 65344-0034

Start Marketing Date : 2021-03-04

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Sacubitril-Valsartan

About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...

Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
Dr Reddy Company Banner

02

Polpharma

Poland
arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content

Sacubitril-Valsartan

About the Company : Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the c...

Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Production of HPAPI with an OEL value of 10 ng/m3 (OEB 6). The HP API investment includes separate process laboratories (PDL), analytical laboratories (ADL) with the possibility of performing QC analyses, and a GMP kilo-lab production line with volume up to 1.5 kg with potential volume increase.
Polpharma CB

03

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Flag Iran
Digital Content Digital Content

Sacubitril-Valsartan

About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...

Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs) and finished dosage forms. For the past three years, the company focused on extracting alkaloid opiates, controlled substances, and narcotics. The APIs are widely used by major pharmaceutical companies nationwide and exported to the Middle East. All production adheres to local GMP standards in an SOP-driven environment with modern systems and utilities, ensuring the highest quality and safety.
Faran Shimi Pharmaceutical

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

Flag India
Digital Content Digital Content

Sacubitril-Valsartan

About the Company : Virupaksha Organics, founded in 2003 by G. Chandra Mouliswar Reddy, is committed to delivering products of the utmost quality to its customers. In a span of less than 20 years, the...

Virupaksha Organics, founded in 2003 by G. Chandra Mouliswar Reddy, is committed to delivering products of the utmost quality to its customers. In a span of less than 20 years, the Hyderabad-based company has grown from a single manufacturing unit to four, employing over 1,000 people. The manufacturing units are situated in Kazipally, Pashamylaram, Humnabad and Gandhi Nagar. Virupaksha's manufacturing facility holds FDA approval, reflecting its adherence to stringent standards. With a customer base exceeding 300 and a presence spanning over 70 countries, Virupaksha has established itself as a reputable global player in its field.
Virupaksha

05

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

Sacubitril-Valsartan

About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...

Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory therapeutic areas, Ami offers a wide range of APIs, intermediates, key starting materials, as well as contract bulk manufacturing services. Ami's manufacturing units in Gujarat and Karnataka feature dedicated clean rooms for APIs and adhere to international standards like EU-GMP, WHO-GMP, PMDA, and COFEPRIS. Ami serves as a reliable partner for contract development and manufacturing, offering generic APIs to global pharma companies across more than 60 countries.
AMI Lifesciences

06

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.

Flag India
Digital Content Digital Content

Sacubitril-Valsartan

About the Company : Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to G...

Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Sacubitril-Valsartan

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content

Sacubitril And Valsartan

About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 40 years of experience in Formulation development, manufacturing and commercialization. It offers a w...

Octavius Pharma is a global leader in Directly Compressible Granules with over 40 years of experience in Formulation development, manufacturing and commercialization. It offers a wide range of products such as tablets, capsules, syrups and ointments. Its portfolio includes finished dosage formulations, herbal/food supplements and APIs. It exports bulk drugs, finished formulations and APIs, while maintaining quality in compliance with WHO GMP norms. With an experienced team, Octavius Pharma provides consulting services for formulation development and marketing. Octavius exports to LATAM, Middle East, African, Asian and CIS countries.
Octavius Pharma

09

Amara Labs

India
Medlab Asia & Asia Health
Not Confirmed
arrow

Amara Labs

India
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitril-Valsartan

About the Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nationals Companies lik...

Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nationals Companies like Mylan and Cipla. We offer Active Pharmaceutical Ingredients, custom synthesis for Domestic, Intermediates for regulated markets with a key focus on new molecules. The manufacturing facility for production is equipped with an ability of producing Active Pharmaceutical Ingredients(API’s) in cGMP standards, with additional facilities of Pilot Plant with a full suite for scaling up and validation of new molecules
blank

10

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitril-Valsartan

About the Company : Divi's Laboratories Limited is a leading independent contract manufacturer of Active Pharmaceutical Ingredients and registered intermediates. We custom / exclusively manufacture fo...

Divi's Laboratories Limited is a leading independent contract manufacturer of Active Pharmaceutical Ingredients and registered intermediates. We custom / exclusively manufacture for several Big Pharma companies under full cGMP. Customers regularly audit our facilities in areas of quality, EHS, business continuity etc. Unmatched Infrastructure:2 manufacturing sites. Both sites were successfully US-FDA Inspected No of DMFs 373 Pilot Plants30 Production Buildings39 Pharma Suites944 Reactors - 250 L to 30 KLTotal Capacity - 6676 M34 R&D Centers325 Scientists.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"SACUBITRIL-VALSARTAN","year":"2021","qtr":"Q1","strtotime":1612290600,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"CT0 SEZ PROCESS ","supplierCountry":"INDIA","foreign_port":"ELEFTHERES","customer":"ELPEN PHARMACEUTICAL","customerCountry":"GREECE","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"4157.2","totalValueFC":"20584.3","currency":"USD","unitRateINR":299735.20000000001,"date":"03-Feb-2021","totalValueINR":"1498676","totalValueInUsd":"20584.3","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29339990","bill_no":"4000071","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"SACUBITRIL-VALSARTAN","year":"2021","qtr":"Q1","strtotime":1616005800,"product":"SACUBITRIL\/VALSARTAN (LCZ696)(DRUG AND D RUGS INTERMEDIATE POWDER FORM)","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"4420.4","totalValueFC":"875","currency":"USD","unitRateINR":318489.14999999997,"date":"18-Mar-2021","totalValueINR":"63697.83","totalValueInUsd":"875","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"9447488","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"SACUBITRIL-VALSARTAN","year":"2021","qtr":"Q1","strtotime":1616005800,"product":"SACUBITRIL\/VALSARTAN (LCZ696)(DRUG AND D RUGS INTERMEDIATE POWDER FORM)","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"13.90","actualQuantity":"13.9","unit":"KGS","unitRateFc":"3799.8","totalValueFC":"52272.1","currency":"USD","unitRateINR":273775.63093525177,"date":"18-Mar-2021","totalValueINR":"3805481.27","totalValueInUsd":"52272.1","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"9447485","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"SACUBITRIL-VALSARTAN","year":"2021","qtr":"Q1","strtotime":1616005800,"product":"SACUBITRIL\/VALSARTAN (LCZ696)(DRUG AND D RUGS INTERMEDIATE POWDER FORM)","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"3799.8","totalValueFC":"94013.5","currency":"USD","unitRateINR":273772.51160000003,"date":"18-Mar-2021","totalValueINR":"6844312.79","totalValueInUsd":"94013.5","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"9447532","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"SACUBITRIL-VALSARTAN","year":"2021","qtr":"Q2","strtotime":1622053800,"product":"SACUBITRIL\/VALSARTAN WORKING STANDARD IMPURITY(DRUG AND DRUGS INTERMEDIATE POW DER FORM)","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"1.16","actualQuantity":"1.155","unit":"KGS","unitRateFc":"13417.8","totalValueFC":"15243.8","currency":"USD","unitRateINR":966753.91341991338,"date":"27-May-2021","totalValueINR":"1116600.77","totalValueInUsd":"15243.8","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"2019894","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"SACUBITRIL-VALSARTAN","year":"2021","qtr":"Q2","strtotime":1622053800,"product":"SACUBITRIL\/VALSARTAN (DRUG AND DRUGS INT","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"TUNIS","customer":"TO ORDER","customerCountry":"TUNISIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"3930","totalValueFC":"11645.2","currency":"USD","unitRateINR":284333.33333333331,"date":"27-May-2021","totalValueINR":"853000","totalValueInUsd":"11645.2","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"2019888","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TUNISIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623695400,"product":"SACUBITRIL\/VALSARTAN IMPURITIES (DRUG AN D DRUGS INTERMEDIATE POWDER FORM)","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"TO ORDER","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.3","unit":"GMS","unitRateFc":"29116","totalValueFC":"8557.2","currency":"USD","unitRateINR":2097810.2000000002,"date":"15-Jun-2021","totalValueINR":"629343.06","totalValueInUsd":"8557.2","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"2434547","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627324200,"product":"SACUBITRIL\/VALSARTAN(DRUG AND DRUGS INTE RMEDIATE POWDER FORM)","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.81","actualQuantity":"0.81","unit":"KGS","unitRateFc":"14512","totalValueFC":"11364","currency":"USD","unitRateINR":1045585.9012345677,"date":"27-Jul-2021","totalValueINR":"846924.58","totalValueInUsd":"11364","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"3409901","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1629657000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TABUK","customer":"TABUK PHARMACEUTICALS","customerCountry":"SAUDI ARABIA","quantity":"41.00","actualQuantity":"41","unit":"KGS","unitRateFc":"2391","totalValueFC":"97149.1","currency":"USD","unitRateINR":175739.09756097561,"date":"23-Aug-2021","totalValueINR":"7205303","totalValueInUsd":"97149.1","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29339990","bill_no":"4000341","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1633545000,"product":"SACUBITRIL\/VALSARTAN USP(DRUG AND DRUGS","address":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E","city":"MUMBAI ,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"15.02","actualQuantity":"15.02","unit":"KGS","unitRateFc":"3800","totalValueFC":"55304.9","currency":"USD","unitRateINR":275832.22370173101,"date":"07-Oct-2021","totalValueINR":"4143000","totalValueInUsd":"55304.9","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"5136432","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX159,A,C.S.T ROAD,KALINA SANTACRUZ(E, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638469800,"product":"SACUBITRIL\/VALSARTAN (DRUG AND DRUGS IN","address":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,","city":"MUMBAI,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"WARSAW","customer":"TO ORDER","customerCountry":"POLAND","quantity":"148.50","actualQuantity":"148.5","unit":"KGS","unitRateFc":"3300","totalValueFC":"480363.9","currency":"USD","unitRateINR":243986.53198653198,"date":"03-Dec-2021","totalValueINR":"36232000","totalValueInUsd":"480363.9","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"6470715","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639593000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"BRAINFARMA IND QUIM E FARM.S.A","customerCountry":"BRAZIL","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2000","totalValueFC":"9837.4","currency":"USD","unitRateINR":148400,"date":"16-Dec-2021","totalValueINR":"742000","totalValueInUsd":"9837.4","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000503","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640889000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"EL QAHIRA (CAIRO)","customer":"AI ANDALOUS FOR PHARMACETICAL","customerCountry":"EGYPT","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1263","totalValueFC":"1242.5","currency":"USD","unitRateINR":93715,"date":"31-Dec-2021","totalValueINR":"93715","totalValueInUsd":"1242.5","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000530","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648233000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"ELPEN PHARMACEUTICAL","customerCountry":"GREECE","quantity":"41.00","actualQuantity":"41","unit":"KGS","unitRateFc":"3490.9","totalValueFC":"141212.9","currency":"USD","unitRateINR":262516.56097560975,"date":"26-Mar-2022","totalValueINR":"10763179","totalValueInUsd":"141212.9","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29336990","bill_no":"4000101","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656527400,"product":"SACUBITRIL\/VALSARTAN(DRUG AND DRUGS INTE","address":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,","city":"MUMBAI,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"6.02","actualQuantity":"6.02","unit":"KGS","unitRateFc":"3800","totalValueFC":"22444.3","currency":"USD","unitRateINR":290863.78737541533,"date":"30-Jun-2022","totalValueINR":"1751000","totalValueInUsd":"22444.3","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"2506742","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658946600,"product":"SACUBITRIL\/VALSARTAN (DRUG AND DRUGS INT","address":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,","city":"MUMBAI,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"45.76","actualQuantity":"45.76","unit":"KGS","unitRateFc":"2400","totalValueFC":"109323.2","currency":"USD","unitRateINR":189969.4055944056,"date":"28-Jul-2022","totalValueINR":"8693000","totalValueInUsd":"109323.2","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"3132054","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666290600,"product":"SACUBITRIL\/VALSARTAN (DRUG AND DRUGS INT","address":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,","city":"MUMBAI,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"14.28","actualQuantity":"14.28","unit":"KGS","unitRateFc":"2400","totalValueFC":"33979.8","currency":"USD","unitRateINR":195798.31932773109,"date":"21-Oct-2022","totalValueINR":"2796000","totalValueInUsd":"33979.8","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"5001982","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672252200,"product":"SACUBITRIL-VALSARTAN 3NA COMPLEX","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"SPEED VENTURES GOODS WHOLESALES","customerCountry":"UNITED ARAB EMIRATES","quantity":"7.80","actualQuantity":"7.8","unit":"KGS","unitRateFc":"8808","totalValueFC":"18214.6","currency":"AED","unitRateINR":192435.89743589744,"date":"29-Dec-2022","totalValueINR":"1501000","totalValueInUsd":"18214.6","indian_port":"HYDERABAD AIR","hs_no":"29334900","bill_no":"6540286","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677781800,"product":"SACUBITRIL\/VALSARTAN (LCZ696) (DRUG AND","address":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,","city":"MUMBAI,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO ORDER","customerCountry":"KOREA, REPUBLIC OF","quantity":"24.95","actualQuantity":"24.95","unit":"KGS","unitRateFc":"2400","totalValueFC":"59294.6","currency":"USD","unitRateINR":195470.94188376755,"date":"03-Mar-2023","totalValueINR":"4877000","totalValueInUsd":"59294.6","indian_port":"BOMBAY AIR","hs_no":"29241900","bill_no":"8234336","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1680287400,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"MANILA","customer":"8SOURCE INC","customerCountry":"PHILIPPINES","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"2391","totalValueFC":"23909.1","currency":"USD","unitRateINR":195944.29999999999,"date":"01-Apr-2023","totalValueINR":"1959443","totalValueInUsd":"23909.1","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000166","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PHILIPPINES","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681669800,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TEL AVIV","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"ISRAEL","quantity":"101.00","actualQuantity":"101","unit":"KGS","unitRateFc":"1265.9","totalValueFC":"126523.2","currency":"USD","unitRateINR":102663.93069306931,"date":"17-Apr-2023","totalValueINR":"10369057","totalValueInUsd":"126523.2","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000200","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687804200,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TBILISI","customer":"GM PHARMACEUTICALS GE GEORGI","customerCountry":"GEORGIA","quantity":"70.00","actualQuantity":"70","unit":"KGS","unitRateFc":"2293.9","totalValueFC":"158923","currency":"USD","unitRateINR":186612.61428571428,"date":"27-Jun-2023","totalValueINR":"13062883","totalValueInUsd":"158923","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000371","productDescription":"API","marketType":"REGULATED MARKET","country":"GEORGIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695753000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA","customerCountry":"BRAZIL","quantity":"393.00","actualQuantity":"393","unit":"KGS","unitRateFc":"2001.2","totalValueFC":"779750","currency":"USD","unitRateINR":164696.33078880407,"date":"27-Sep-2023","totalValueINR":"64725658","totalValueInUsd":"779750","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29333990","bill_no":"4000606","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696271400,"product":"SACUBITRIL\/VALSARTAN I","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"SAO PAULO","customer":"APSEN FARMACEUTICA SA","customerCountry":"BRAZIL","quantity":"60.00","actualQuantity":"60","unit":"KGS","unitRateFc":"1800","totalValueFC":"106794.1","currency":"USD","unitRateINR":148140,"date":"03-Oct-2023","totalValueINR":"8888400","totalValueInUsd":"106794.1","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29333990","bill_no":"4000623","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698345000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"XXNTHXXCHEXXE LXX","customerCountry":"COLOMBIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2945","totalValueFC":"5834.9","currency":"USD","unitRateINR":242815.5,"date":"27-Oct-2023","totalValueINR":"485631","totalValueInUsd":"5834.9","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29333990","bill_no":"4000684","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700073000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TEL AVIV","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"ISRAEL","quantity":"102.00","actualQuantity":"102","unit":"KGS","unitRateFc":"1270","totalValueFC":"128185.5","currency":"USD","unitRateINR":104648.25490196078,"date":"16-Nov-2023","totalValueINR":"10674122","totalValueInUsd":"128185.5","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000742","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700073000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TEL AVIV","customer":"XX. RXXDY XXLABXXATOXXES XXA.","customerCountry":"ISRAEL","quantity":"306.00","actualQuantity":"306","unit":"KGS","unitRateFc":"1265.8","totalValueFC":"383267.8","currency":"USD","unitRateINR":104297.5522875817,"date":"16-Nov-2023","totalValueINR":"31915051","totalValueInUsd":"383267.8","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000742","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703529000,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TEL AVIV","customer":"XX. RXXDY XXLABXXATOXXES XXA.","customerCountry":"ISRAEL","quantity":"100.00","actualQuantity":"100","unit":"KGA","unitRateFc":"1274.4","totalValueFC":"126606.7","currency":"USD","unitRateINR":105391.41,"date":"26-Dec-2023","totalValueINR":"10539141","totalValueInUsd":"126606.7","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29333990","bill_no":"4000850","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710268200,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TEL AVIV","customer":"DR.REEDDY'S LABORATORIES S.A","customerCountry":"ISRAEL","quantity":"95.00","actualQuantity":"95","unit":"KGS","unitRateFc":"1267.3","totalValueFC":"118889.7","currency":"USD","unitRateINR":103916.88421052632,"date":"13-Mar-2024","totalValueINR":"9872104","totalValueInUsd":"118889.7","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29334900","bill_no":"4000183","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715020200,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"TEL AVIV","customer":"XX. RXXDY'XXLABXXATOXXES XXA.","customerCountry":"ISRAEL","quantity":"101.00","actualQuantity":"101","unit":"KGS","unitRateFc":"1267.3","totalValueFC":"126844","currency":"USD","unitRateINR":104682.91089108911,"date":"07-May-2024","totalValueINR":"10572974","totalValueInUsd":"126844","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000334","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717612200,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"BEACON PHARMACEUTICALS LIMITED","customerCountry":"BANGLADESH","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1445.1","totalValueFC":"1430.8","currency":"USD","unitRateINR":119441,"date":"06-Jun-2024","totalValueINR":"119441","totalValueInUsd":"1430.8","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000423","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718994600,"product":"SACUBITRIL\/VALSARTAN IH","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"CT0 SEZ PROCESS ","supplierCountry":"INDIA","foreign_port":"TEL AVIV","customer":"XX. RXXDY'XXLABXXATOXXES XXA.","customerCountry":"ISRAEL","quantity":"402.00","actualQuantity":"402","unit":"KGS","unitRateFc":"1261.4","totalValueFC":"501752.5","currency":"USD","unitRateINR":104194.05970149254,"date":"22-Jun-2024","totalValueINR":"41886012","totalValueInUsd":"501752.5","indian_port":"Reddy r-SEZ\/Srikakulam","hs_no":"29332990","bill_no":"4000464","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Reddy r-SEZ\/Srikakulam","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""}]
03-Feb-2021
22-Jun-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

INTERMEDIATES SUPPLIERS

read-more
read-more

01

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 1426129-50-1

End Use API : Sacubitril-Valsartan

About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...

blank

02

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 1038924-61-6

End Use API : Sacubitril-Valsartan

About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...

blank

03

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 1012341-50-2

End Use API : Sacubitril-Valsartan

About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...

blank

04

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 149690-12-0

End Use API : Sacubitril-Valsartan

About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...

blank

05

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 1012341-48-8

End Use API : Sacubitril-Valsartan

About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...

blank

06

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 1369773-39-6

End Use API : Sacubitril-Valsartan

About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

blank

07

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 1426129-50-1

End Use API : Sacubitril-Valsartan

About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

blank

08

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 1012341-50-2

End Use API : Sacubitril-Valsartan

About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

blank

09

Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed
arrow

CAS Number : 149690-12-0

End Use API : Sacubitril-Valsartan

About The Company : Shanghai Stepuppharm has a strong technical development troop and most of our technological backbone are Senior R&D persons and have more than 10 years experien...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitrilum-Valsartanum

Brand Name : Entresto

Dosage Form : Film-Coated Tablets

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitrilum-Valsartanum

Brand Name : Entresto

Dosage Form : Film-Coated Tablets

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitrilum-Valsartanum

Brand Name : Entresto

Dosage Form : Film-Coated Tablets

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitrilum-Valsartanum

Brand Name : Entresto

Dosage Form : Film-Coated Tablets

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitrilum-Valsartanum

Brand Name : Entresto

Dosage Form : Filmtabl

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

Sacubitrilum-Valsartanum

Brand Name : Entresto

Dosage Form : Film-Coated Tablets

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more
DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   

Impressions: 6493

https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

#PharmaFlow by PHARMACOMPASS
24 Oct 2024

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty